Record overview
Status and phase
Status: NOT_YET_RECRUITING
Phase: PHASE2
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Condition: Ph- Acute Lymphoblastic Leukemia (Ph-ALL)
NCT07643103
Immuno-Targeted Therapy Plus Low-Dose Chemotherapy for Newly Diagnosed Adult Ph-Negative B-ALL: A Prospective Umbrella Trial
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: None
Results signal: Low Signal
Operational burden: complex_intervention_signal
Stopped reason
Context when available
No stop reason available in the current public record.